Skip to Main content Skip to Navigation
Journal articles

Lichen butyrolactone derivatives disrupt oral bacterial membrane

Abstract : We have previously demonstrated that out of the butyrolactones series synthesized based on the natural lichen metabolite lichesterinic acid, compound (B-13) was the most effective against oral bacteria. However, its antibacterial mechanism is still unknown. In this study, we have investigated its bacterial localization by synthesizing a fluorescently labeled B-13 with NBD while maintaining its antibacterial activity. We showed that this compound binds to Streptococcus gordonii cell surface, as demonstrated by HPLC analysis. By adhering to cell surface, B-13 induced cell wall disruption leading to the release of bacterial constituents and consequently, the death of S. gordonii, a Gram-positive bacterium. A Gram-negative counterpart, Porphyromanas gingivalis, showed also cracked and ruptured cells in the presence of B-13. Besides, we also demonstrated that the analog of B-13, B-12, has also induced disruption of P. gingivalis and S. gordonii. This study revealed that butyrolactones can be considered as potent antibacterial compounds against oral pathogens causing medical complications.
Complete list of metadata

Cited literature [42 references]  Display  Hide  Download
Contributor : Laurent Jonchère <>
Submitted on : Tuesday, February 11, 2020 - 1:51:40 PM
Last modification on : Thursday, August 12, 2021 - 5:02:58 PM
Long-term archiving on: : Tuesday, May 12, 2020 - 1:57:57 PM


Sweidan-2019-Lichen butyrolact...
Files produced by the author(s)



Alaa Sweidan, Imen Smida, Marylene Chollet-Krugler, Aurélie Sauvager, Julien Vallet, et al.. Lichen butyrolactone derivatives disrupt oral bacterial membrane. Fitoterapia, Elsevier, 2019, 137, pp.104274. ⟨10.1016/j.fitote.2019.104274⟩. ⟨hal-02280840⟩



Record views


Files downloads